<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!-- saved from url=(0052)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/ -->
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="brjclinpharm"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC1874466/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="./PMC1874466_files/jig.min.css"><script type="text/javascript" src="./PMC1874466_files/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="British Journal of Clinical Pharmacology"><meta name="citation_title" content="Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers"><meta name="citation_authors" content="Paul D Martin, Patrick D Mitchell, Dennis W Schneck"><meta name="citation_date" content="November 2002"><meta name="citation_issue" content="5"><meta name="citation_volume" content="54"><meta name="citation_firstpage" content="472"><meta name="citation_doi" content="10.1046/j.1365-2125.2002.01688.x"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1874466/?report=abstract"><meta name="citation_pmid" content="12445025"><meta name="DC.Title" content="Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Wiley-Blackwell"><meta name="DC.Contributor" content="Paul D Martin"><meta name="DC.Contributor" content="Patrick D Mitchell"><meta name="DC.Contributor" content="Dennis W Schneck"><meta name="DC.Date" content="2002 Nov"><meta name="DC.Identifier" content="10.1046/j.1365-2125.2002.01688.x"><meta name="DC.Language" content="en"><meta property="og:title" content="Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers"><meta property="og:type" content="article"><meta property="og:description" content="To compare the lipid-regulating effects and steady-state pharmacokinetics of rosuvastatin, a new synthetic hydroxy methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, following repeated morning and evening administration in volunteers with fasting ..."><meta property="og:url" content="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="./PMC1874466_files/pmc.min.css" type="text/css"><link rel="stylesheet" href="./PMC1874466_files/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="./PMC1874466_files/common.min.js">//</script><script type="text/javascript" src="./PMC1874466_files/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:&#39;/pmc/utils/ctxp/&#39;"><script type="text/javascript" src="./PMC1874466_files/jquery.citationexporter.js">//</script><link rel="stylesheet" href="./PMC1874466_files/citationexporter.css" type="text/css"><script type="text/javascript" src="./PMC1874466_files/MathJax.js"></script><script type="text/javascript" src="./PMC1874466_files/large-obj-scrollbars.min.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-brjclinpharm.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><link rel="alternate" type="application/epub+zip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/epub/"><link rel="alternate" type="application/pdf" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/pdf/bcp0054-0472.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="http://www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="F4FB6D6876C256210000000000B37D55"><link type="text/css" rel="stylesheet" href="./PMC1874466_files/3855312.css"><link type="text/css" rel="stylesheet" href="./PMC1874466_files/3929378.css" media="print"><style type="text/css" media="print">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('http://www.ncbi.nlm.nih.gov/stat?jsevent=print&ncbi_app=pmc&ncbi_db=pmc&ncbi_pcid=%2Farticles%2FPMC1874466%2F&ncbi_pdid=article&ncbi_phid=F4FB6D6876C256210000000000B37D55'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-jig-5"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="http://www.ncbi.nlm.nih.gov/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="./PMC1874466_files/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a><ul id="resources-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/" tabindex="-1" role="menuitem">All Resources</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#chemicals-bioassays" tabindex="-1" role="menuitem" class="expandRight">Chemicals &amp; Bioassays</a><ul class="actual-resources-submenu chemicals-bioassays ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcassay" title=" Contributed bioactivity data for PubChem Substances " tabindex="-1" role="menuitem">PubChem BioAssay</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pccompound" title=" Unique, standardized chemical structures " tabindex="-1" role="menuitem">PubChem Compound</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcsubstance" title=" Provides information on the biological activities of small molecules. " tabindex="-1" role="menuitem">PubChem Substance</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/" tabindex="-1" role="menuitem">All Chemicals &amp; Bioassays Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#dna-rna" tabindex="-1" role="menuitem" class="expandRight">DNA &amp; RNA</a><ul class="actual-resources-submenu dna-rna ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/" title=" DNA and RNA sequences submitted to NCBI " tabindex="-1" role="menuitem">GenBank</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/" tabindex="-1" role="menuitem">All DNA &amp; RNA Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#data-software" tabindex="-1" role="menuitem" class="expandRight">Data &amp; Software</a><ul class="actual-resources-submenu data-software ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/" tabindex="-1" role="menuitem">All Data &amp; Software Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#domains-structures" tabindex="-1" role="menuitem" class="expandRight">Domains &amp; Structures</a><ul class="actual-resources-submenu domains-structures ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/structure/" title=" Database of 3D macromolecular structures derived from PDB " tabindex="-1" role="menuitem">Structure (Molecular Modeling Database)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/" tabindex="-1" role="menuitem">All Domains &amp; Structures Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#genes-expression" tabindex="-1" role="menuitem" class="expandRight">Genes &amp; Expression</a><ul class="actual-resources-submenu genes-expression ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gene" title=" Database of gene loci and associated transcripts and proteins " tabindex="-1" role="menuitem">Gene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geo/" title=" Gene Expression Omnibus (GEO) Database " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Database </a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gds" title=" Curated collections of gene expression data sets " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Datasets</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geoprofiles/" title=" Database of gene expression Profiles for individual sequences " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Profiles</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/" tabindex="-1" role="menuitem">All Genes &amp; Expression Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#genetics-medicine" tabindex="-1" role="menuitem" class="expandRight">Genetics &amp; Medicine</a><ul class="actual-resources-submenu genetics-medicine ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gtr/" title=" Detailed information about genetic tests and labs " tabindex="-1" role="menuitem">Genetic Testing Registry</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/" tabindex="-1" role="menuitem">All Genetics &amp; Medicine Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#genomes-maps" tabindex="-1" role="menuitem" class="expandRight">Genomes &amp; Maps</a><ul class="actual-resources-submenu genomes-maps ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sites/genome" title=" Curated genomic DNA sequences " tabindex="-1" role="menuitem">Genome</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/bioproject/" title=" Central status pages for genome sequencing projects " tabindex="-1" role="menuitem">Genome Project</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/" tabindex="-1" role="menuitem">All Genomes &amp; Maps Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#homology" tabindex="-1" role="menuitem" class="expandRight">Homology</a><ul class="actual-resources-submenu homology ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/" tabindex="-1" role="menuitem">All Homology Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#literature" tabindex="-1" role="menuitem" class="expandRight">Literature</a><ul class="actual-resources-submenu literature ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nlmcatalog/journals" title=" Information on journals cited by NCBI records " tabindex="-1" role="menuitem">Journals in NCBI Databases</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mesh" title=" Controlled vocabulary for MEDLINE " tabindex="-1" role="menuitem">MeSH Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/" title=" Reviews of clinical effectiveness research " tabindex="-1" role="menuitem">PubMed Health</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/" tabindex="-1" role="menuitem">All Literature Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#proteins" tabindex="-1" role="menuitem" class="expandRight">Proteins</a><ul class="actual-resources-submenu proteins ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/protein" title=" Protein sequence data " tabindex="-1" role="menuitem">Protein Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/" tabindex="-1" role="menuitem">All Proteins Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#sequence-analysis" tabindex="-1" role="menuitem" class="expandRight">Sequence Analysis</a><ul class="actual-resources-submenu sequence-analysis ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/" tabindex="-1" role="menuitem">All Sequence Analysis Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#taxonomy" tabindex="-1" role="menuitem" class="expandRight">Taxonomy</a><ul class="actual-resources-submenu taxonomy ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/taxonomy" title=" The NCBI taxonomy tree in Entrez " tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Root" title=" Displays and links Entrez data to each taxonomic node " tabindex="-1" role="menuitem">Taxonomy Browser</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/wwwcmt.cgi" title=" Creates custom taxonomic trees " tabindex="-1" role="menuitem">Taxonomy Common Tree</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/" tabindex="-1" role="menuitem">All Taxonomy Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#training-tutorials" tabindex="-1" role="menuitem" class="expandRight">Training &amp; Tutorials</a><ul class="actual-resources-submenu training-tutorials ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/education/" title=" Central page providing links to tutorials and training materials " tabindex="-1" role="menuitem">NCBI Education Page</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/" tabindex="-1" role="menuitem">All Training &amp; Tutorials Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#variation" tabindex="-1" role="menuitem" class="expandRight">Variation</a><ul class="actual-resources-submenu variation ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/snp" title=" Database of nucleotide sequence polymorphisms " tabindex="-1" role="menuitem">Database of Single Nucleotide Polymorphisms (dbSNP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/" tabindex="-1" role="menuitem">All Variation Resources...</a></li></ul></li></ul></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a><ul id="howto-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/#howtos" tabindex="-1" role="menuitem">All How To</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/#howtos" tabindex="-1" role="menuitem">Chemicals &amp; Bioassays</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/#howtos" tabindex="-1" role="menuitem">DNA &amp; RNA</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/#howtos" tabindex="-1" role="menuitem">Data &amp; Software</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/#howtos" tabindex="-1" role="menuitem">Domains &amp; Structures</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/#howtos" tabindex="-1" role="menuitem">Genes &amp; Expression</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/#howtos" tabindex="-1" role="menuitem">Genetics &amp; Medicine</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/#howtos" tabindex="-1" role="menuitem">Genomes &amp; Maps</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/#howtos" tabindex="-1" role="menuitem">Homology</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/#howtos" tabindex="-1" role="menuitem">Literature</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/#howtos" tabindex="-1" role="menuitem">Proteins</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/#howtos" tabindex="-1" role="menuitem">Sequence Analysis</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/#howtos" tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/#howtos" tabindex="-1" role="menuitem">Training &amp; Tutorials</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/#howtos" tabindex="-1" role="menuitem">Variation</a></li></ul></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="http://www.ncbi.nlm.nih.gov/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="http://www.ncbi.nlm.nih.gov/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1874466%2F" id="sign_in">Sign in to NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/signout/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1874466%2F" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="http://www.ncbi.nlm.nih.gov/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="http://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="http://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="http://www.ncbi.nlm.nih.gov/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbook">ToolKitBook</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" config="dictionary:&#39;pmc-search-autocomplete&#39;,disableUrl:&#39;NcbiSearchBarAutoComplCtrl&#39;" autocomplete="off" data-sbconfig="ds:&#39;no&#39;,pjs:&#39;no&#39;,afs:&#39;yes&#39;" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" style="visibility: hidden;"><img src="./PMC1874466_files/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/limits/">Limits</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="http://www.ncbi.nlm.nih.gov/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="http://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a></li><li class="archive-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/journals/279/">Br J Clin Pharmacol</a></li><li class="issue-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/issues/144393/">v.54(5); 2002 Nov</a></li><li class="accid">PMC1874466</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="./PMC1874466_files/logo-brjclinpharm.gif" alt="Logo of brjclinpharm" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher&#39;s site" title="Link to Publisher&#39;s site" shape="default" coords="0,0,499,74" href="http://www.blackwellpublishing.com/journal.asp?ref=0306-5251" target="pmc_ext" ref="reftype=publisher&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [&#39;h2&#39;], headingExclude: &#39;:hidden&#39;" id="ui-jig-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit">Br J Clin Pharmacol. 2002 Nov; 54(5): 472–477. </span></div><div>  <span class="doi">doi:&nbsp; <a href="http://dx.doi.org/10.1046%2Fj.1365-2125.2002.01688.x" target="pmc_ext" ref="reftype=other&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1046/j.1365-2125.2002.01688.x</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1874466</span></div></div></div></div></div><h1 class="content-title">Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Martin%20PD%5Bauth%5D">Paul D Martin</a>,<sup>1</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mitchell%20PD%5Bauth%5D">Patrick D Mitchell</a>,<sup>2</sup> and  <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Schneck%20DW%5Bauth%5D">Dennis W Schneck</a><sup>2</sup></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="id616466_ai" style="display:none"><div class="fm-affl" lang="en"><sup>1</sup>AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK</div><div class="fm-affl" lang="en"><sup>2</sup>AstraZeneca, Wilmington, Delaware, USA</div><div id="cor1"><em>Correspondence:</em> Dennis W. Schneck, AstraZeneca R &amp; D Wilmington, AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Fairfax OW3, PO Box 15437, Wilmington, DE 19850-5437, USA. Tel.: + 1 302 886 5904; Fax: + 1 302 886 1099; E-mail: <a href="mailto:dev@null" data-email="moc.acenezartsa@kcenhcs.sinned" class="oemail">moc.acenezartsa@kcenhcs.sinned</a></div><div id="__fnid897987">Rosuvastatin is licensed from Shionogi and Co. Ltd, Osaka, Japan.</div></div><div class="togglers"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" class="pmctoggle" rid="id616466_ai">Author information <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" class="pmctoggle" rid="id616466_an">Article notes <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" class="pmctoggle" rid="id616466_cpl">Copyright and License information <span>►</span></a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="id616466_an" style="display:none"><div class="fm-pubdate half_rhythm">Accepted 2002 Aug 8.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="id616466_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright</a> © 2002 Blackwell Science Ltd</div></div></div><div class="links-box fm-panel whole_rhythm"><div class="small"><div>This article has been <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="__abstractid898026" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-7"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true" id="ui-jig-8">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__abstractid898026title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3>Aims</h3><p id="__p2" class="p p-first-last">To compare the lipid-regulating effects and steady-state pharmacokinetics of rosuvastatin, a new synthetic hydroxy methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, following repeated morning and evening administration in volunteers with fasting serum low-density lipoprotein cholesterol (LDL-C) concentrations &lt; 4.14 mmol l<sup>−1</sup>.</p></div><div id="__sec2" class="sec"><h3>Methods</h3><p id="__p3" class="p p-first-last">In this open-label two-way crossover trial 24 healthy adult volunteers were randomized to receive rosuvastatin 10 mg orally each morning (07.00 h) or evening (18.00 h) for 14 days. After a 4 week washout period, volunteers received the alternative regimen for 14 days. Rosuvastatin was administered in the absence of food.</p></div><div id="__sec3" class="sec"><h3>Results</h3><p id="__p4" class="p p-first-last">Reductions from baseline in serum concentrations of LDL-C (−41.3% [morning] <em>vs</em> −44.2% [evening]), total cholesterol (−30.9% <em>vs</em> −31.8%), triglycerides (−17.1% <em>vs</em> −22.7%), and apolipoprotein B (−32.4% <em>vs</em> −35.3%) were similar following morning and evening administration. AUC(0,24 h) for plasma mevalonic acid (MVA), an <em>in vivo</em> marker of HMG-CoA reductase activity, decreased by −29.9% (morning) <em>vs</em> −32.6% (evening). Urinary excretion of MVA declined by −33.6% (morning) <em>vs</em> −29.2% (evening). The steady-state pharmacokinetics of rosuvastatin were very similar following the morning and evening dosing regimens. The <em>C</em><sub>max</sub> values were 4.58 <em>vs</em> 4.54 ng ml<sup>−1</sup>, and AUC(0,24 h) values were 40.1 <em>vs</em> 42.7 ng ml<sup>−1</sup> h, following morning and evening administration, respectively. There were no serious adverse events during the trial, and rosuvastatin was well tolerated after morning and evening administration.</p></div><div id="__sec4" class="sec sec-last"><h3>Conclusions</h3><p id="__p5" class="p p-first-last">The pharmacodynamic effects and pharmacokinetics of rosuvastatin are not dependent on time of dosing. Morning or evening administration is equally effective in lowering LDL-C.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">HMG-CoA reductase, LDL-C, morning/evening dosing, rosuvastatin</span></div></div><div id="__sec5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-9"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-10">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec5title">Introduction</h2><p id="__p6" class="p p-first">Hydroxy methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) currently form the mainstay of lipid-regulating therapy, and are the most effective agents for reducing serum cholesterol concentrations and cardiovascular mortality [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b1" rid="b1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035842" role="button" aria-expanded="false" aria-haspopup="true">1</a>–<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b3" rid="b3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035836" role="button" aria-expanded="false" aria-haspopup="true">3</a>]. As competitive inhibitors of HMG-CoA reductase, statins block an early rate-limiting step in cholesterol biosynthesis: the conversion of HMG-CoA to mevalonate [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b4" rid="b4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035835" role="button" aria-expanded="false" aria-haspopup="true">4</a>]. Inhibition of hepatic cholesterol production results in up-regulation of hepatic low-density lipoprotein receptors, which are responsible for the clearance of circulating low-density lipoprotein cholesterol (LDL-C), and reduced hepatic secretion of very-low-density lipoprotein particles [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b5" rid="b5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035839" role="button" aria-expanded="false" aria-haspopup="true">5</a>–<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b7" rid="b7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035827" role="button" aria-expanded="false" aria-haspopup="true">7</a>].</p><p id="__p7">Since hepatic HMG-CoA reductase activity [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b8" rid="b8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035841" role="button" aria-expanded="false" aria-haspopup="true">8</a>] and cholesterol biosynthesis [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b9" rid="b9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035826" role="button" aria-expanded="false" aria-haspopup="true">9</a>] are greatest at night (circadian variation) it is generally recommended that statins be administered in the evening or at bedtime for maximal effect [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b2" rid="b2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035837" role="button" aria-expanded="false" aria-haspopup="true">2</a>]. The lipid-regulating effects of most available statins – including fluvastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b10" rid="b10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035830" role="button" aria-expanded="false" aria-haspopup="true">10</a>], lovastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b11" rid="b11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035843" role="button" aria-expanded="false" aria-haspopup="true">11</a>], pravastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b12" rid="b12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035831" role="button" aria-expanded="false" aria-haspopup="true">12</a>], and simvastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b13" rid="b13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035820" role="button" aria-expanded="false" aria-haspopup="true">13</a>]– are reported to be influenced by the time of dosing, and are less pronounced following morning compared with evening administration.</p><p id="__p8">Rosuvastatin (Crestor®) is a new and highly effective inhibitor of HMG-CoA reductase that has completed Phase-III clinical development for the treatment of patients with dyslipidaemia. In clinical trials, rosuvastatin (1–80 mg) produced reductions in LDL-C, total cholesterol (TC), and triglycerides (TG), and increases in high-density lipoprotein cholesterol (HDL-C) [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b14" rid="b14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035834" role="button" aria-expanded="false" aria-haspopup="true">14</a>–<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b18" rid="b18" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">18</a>].</p><p id="__p9">The pharmacokinetics of rosuvastatin following single- and multiple-dose administration of the drug to healthy volunteers have been investigated in a number of trials [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b19" rid="b19" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">19</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b20" rid="b20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_384332749" role="button" aria-expanded="false" aria-haspopup="true">20</a>, AstraZeneca data on file<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#fn1" rid="fn1" class=" fn">†</a></sup>]. Following multiple oral doses of rosuvastatin (20, 40, and 80 mg) AUC(0,24 h) and <em>C</em><sub>max</sub> were essentially dose proportional, time to <em>C</em><sub>max</sub> ranged from 3 to 5 h, and the terminal elimination half-life ranged from 13 to 21 h.</p><p id="__p10" class="p p-last">This trial (4522IL/0004) was conducted to compare the pharmacodynamics and multiple-dose pharmacokinetics of rosuvastatin following morning and evening administration in healthy adult volunteers.</p></div><div id="__sec6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-11"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-12">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec6title">Methods</h2><p id="__p11" class="p p-first">Twenty-four healthy adult volunteers (22 men and 2 women), ranging in age from 19 to 61 years (mean 38.6 years) and weighing 57–100 kg (mean 76.9 kg), were enrolled in this trial. Of these, 21 were Caucasian, 2 were Hispanic, and 1 was Black.</p><p id="__p12" class="p">Screening assessments included a complete medical history, physical examination, 12-lead electrocardiogram (ECG), and standard laboratory tests. All volunteers had fasting serum LDL-C concentrations &lt; 4.14 mmol l<sup>−1</sup> and fasting serum TG concentrations ≤ 3.39 mmol l<sup>−1</sup>. Clinical chemistry (including hepatic function) tests were within reference ranges. Each volunteer provided written in-formed consent prior to enrolment.</p><div id="__sec7" class="sec sec-last"><h3>Trial design</h3><p id="__p13" class="p p-first">This open-label, randomized, two-way crossover trial comprised two 14 day treatment periods separated by a 4 week washout period. Dietary assessments were made during a pre-treatment screening period of 21–30 days, and dietary regimens were developed to stabilize individual calorie and fat intake during the trial (thereby minimizing potential dietary effects on lipid levels). Volunteers entered the clinic 2 days before treatment began and remained there for each 14 day treatment period and for a 4 day follow-up period.</p><p id="__p14">Eligible volunteers were randomized to receive a single oral dose of rosuvastatin (10 mg) each morning (approximately 07.00 h) or evening (approximately 18.00 h) for 14 days. After the washout period volunteers received the alternative (morning or evening) treatment regimen for a further 14 days. The trial medication was administered with 240 ml of water. Volunteers were required to fast for a minimum of 2 h before and after each rosuvastatin dose, and for at least 12 h (overnight) before collection of blood samples for lipid analyses.</p><p id="__p15" class="p p-last">The trial was conducted in compliance with Good Clinical Practice and the ethical principles of the Declaration of Helsinki. The Ethics Committee and Institutional Review Board of Covance in Madison, Wisconsin, USA approved the trial protocol.</p></div></div><div id="__sec8" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-13"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-14">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec8title">Pharmacodynamic evaluations</h2><p id="__p16" class="p p-first">Blood samples (10 ml) were collected for determination of fasting serum lipid concentrations before administration of the morning dose of rosuvastatin (morning dosing) or before the morning meal (evening dosing). Serum LDL-C (the primary parameter of this trial), TC, TG, HDL-C, apolipoprotein A-I (ApoA-I), and apolipoprotein B (ApoB) concentrations were determined at screening (days −21 and −1), on treatment days 1, 7, 13, and 14, at follow-up (days 1 and 4 post-treatment), and at weekly intervals during the washout period. Serum samples were stored at −20 °C prior to analysis, which was conducted at a central laboratory (Covance Laboratories, Indiana, USA). LDL-C concentrations were calculated using the Friedewald formula [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b21" rid="b21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035824" role="button" aria-expanded="false" aria-haspopup="true">21</a>]. TC and TG were measured by colorimetric enzymatic assay (using a Hitachi 747 automatic analyser). HDL-C was measured after precipitation by colorimetric enzymatic assay. ApoA-I and ApoB were measured by nephelometry.</p><p id="__p17" class="p">During each treatment period, plasma concentrations of mevalonic acid (MVA). an <em>in vivo</em> marker of HMG-CoA reductase activity, were measured at baseline (day −1), on treatment days 1 and 14, and at follow-up (day 1 post-treatment). In addition, urinary MVA excretion was determined over a 24 h period before the first dose and after the final dose of rosuvastatin in each treatment period. Heparinized plasma samples and urine samples were stored at −70 °C prior to analysis. The analysis of plasma MVA concentrations was performed using a validated h.p.l.c./MS/MS [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b22" rid="b22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341071725" role="button" aria-expanded="false" aria-haspopup="true">22</a>] method at Covance Laboratories, Harrogate, UK. Correlation coefficients for plasma MVA were 0.991–1.00. Mean accuracy levels for quality control samples (at all concentrations) were 99.7–106.7%; mean imprecision values were 7.2–10.9%. The limit of quantification for plasma MVA in this trial was 0.2 ng ml<sup>−1</sup>. The analysis of urine MVA concentrations was performed using a validated GC/MS assay [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b23" rid="b23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341071724" role="button" aria-expanded="false" aria-haspopup="true">23</a>] at AstraZeneca's Central Toxicology Laboratory, Alderley Park, Cheshire, UK. Correlation coefficients for urine MVA were 0.993–1.00. Mean accuracy levels for quality control samples (at all concentrations) were 86.6–103%. The limit of quantification for urine MVA in this trial was 9.0 ng ml<sup>−1</sup>.</p><div id="__sec9" class="sec"><h3>Pharmacokinetics</h3><p id="__p18" class="p p-first">Serial venous blood samples (7 ml) for determination of plasma rosuvastatin concentrations were collected at 0.5 h predose and at fixed intervals (0.5, 1, 2, 3, 4, 5, 6, 8, 10, 12, 18, 24, 48, and 72 h) after administration of rosuvastatin on treatment day 14. Blood samples were also collected at 0.5 h pre-dose on treatment days 2, 3, 7, 8, and 13 to assess whether pharmacokinetic steady state had been attained. Heparinized blood samples were centrifuged at 1500–2500 rev min<sup>−1</sup> for 10 min. The derived plasma samples were diluted 1 : 1 with 0.1 <span class="small-caps">m</span> sodium acetate buffer (pH 4.0) and stored at −70 °C prior to analysis. Plasma concentrations of rosuvastatin were determined using a validated h.p.l.c./MS assay [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b24" rid="b24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341071726" role="button" aria-expanded="false" aria-haspopup="true">24</a>] at Quintiles, Edinburgh, UK. Correlation coefficients for rosuvastatin were 0.994–1.00. Mean inaccuracy levels and imprecision values for quality control samples (at all concentrations) were ≤ 7% and &lt; 8%, respectively. The limit of quantification for rosuvastatin in this trial was 0.2 ng ml<sup>−1</sup>.</p><p id="__p19" class="p p-last">Plasma rosuvastatin concentration-time data were analysed by standard noncompartmental pharmacokinetic methods. The following parameters were determined: maximum plasma concentration (<em>C</em><sub>max</sub>), time to <em>C</em><sub>max</sub> (<em>t</em><sub>max</sub>), area under the plasma concentration-time curve from time zero to 24 h (AUC(0,24 h)), AUC from time zero to infinity (AUC(0,∞)), and the plasma terminal elimination half-life (<em>t</em><sub>1/2</sub>). AUC was estimated using the linear trapezoidal method, with extrapolation from the last quantifiable data point using the terminal slope of the plasma concentration-time profile. The terminal elimination rate constant (λ<sub>z</sub>) was derived by log-linear regression of the terminal portion of the plasma concentration-time profile, and <em>t</em><sub>1/2</sub> was calculated as ln2/λ<sub>z</sub>.</p></div><div id="__sec10" class="sec"><h3>Safety and tolerability assessments</h3><p id="__p20" class="p p-first-last">Safety and tolerability were assessed from routine laboratory tests, haemodynamic monitoring, and clinical adverse event records.</p></div><div id="__sec11" class="sec sec-last"><h3>Statistical analysis</h3><p id="__p21" class="p p-first">Sample size estimates showed that 16 volunteers would be required in order to provide 80% power to detect an absolute treatment difference (morning-evening) of 10% in mean percent reduction in LDL-C concentration. Assuming a trial discontinuation rate of 33%, 24 volunteers were required for enrollment.</p><p id="__p22" class="p p-last">For morning <em>vs</em> evening comparisons of lipid parameters, MVA concentrations, and pharmacokinetic parameters an analysis of variance (<span class="small-caps">anova</span>) model was used (with effects for treatment sequence, volunteer-within-treatment sequence, treatment group, and period). Mean percent changes in lipid parameters from baseline were compared using least square means generated by <span class="small-caps">anova</span> of lipid parameters and expressed as morning-evening differences with 90% confidence intervals (CIs). Mean percent change in MVA concentrations from baseline were compared using least square geometric means generated by <span class="small-caps">anova</span> of plasma MVA AUC(0,24 h) and urinary excretion of MVA and expressed as morning-evening differences with 90% CIs. Plasma rosuvastatin exposure was compared using least square geometric means generated by <span class="small-caps">anova</span> of log-transformed rosuvastatin AUC(0,24 h) and <em>C</em><sub>max</sub> values and expressed as morning/evening ratios with 90% CIs.</p></div></div><div id="__sec12" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-15"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-16">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec12title">Results</h2><p id="__p23" class="p p-first">Of the 24 volunteers enrolled in this trial, 21 were included in the pharmacodynamic and pharmacokinetic analyses. Three volunteers were withdrawn because of protocol noncompliance (<em>n</em> = 1), loss to follow-up after the first treatment period (<em>n</em> = 1), and a nonserious adverse event (<em>n</em> = 1). All 24 volunteers were included in the safety analysis.</p><div id="__sec13" class="sec"><h3>Pharmacodynamics</h3><p id="__p24" class="p p-first">Similar marked reductions in serum LDL-C were obtained following once daily administration of rosuvastatin 10 mg in the morning or evening. After 14 days of treatment, the mean reductions from baseline in serum LDL-C concentration with the morning and evening regimens were −41.3% and −44.2%, respectively (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl1/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>). Any difference between treatments greater than 6%, was excluded by the 90% CIs.</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="tbl1"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl1/" target="table" rid-ob="ob-tbl1" rid-figpopup="tbl1" class="table img_link icnblk_img figpopup"><img alt="Table 1" title="Table 1" class="small-thumb" src="./PMC1874466_files/saved_resource" src-large="/pmc/articles/PMC1874466/table/tbl1/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl1/" target="table" rid-figpopup="tbl1" rid-ob="ob-tbl1">Table 1</a></div><!--caption a4--><div><span>Summary of serum lipid and lipoprotein concentrations after morning and evening administration of rosuvastatin.</span></div></div></div><p id="__p25">Likewise, the reductions in serum TC (−30.9% <em>vs</em> −31.8%), TG (−17.1% <em>vs</em> −22.7%), ApoA-I (−6.0% <em>vs</em> −3.4%), and ApoB (−32.4% <em>vs</em> −35.3%) concentrations were similar following morning and evening administration (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl1/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>).</p><p id="__p26">Serum HDL-C showed a greater reduction following morning compared with evening administration (−9.6% <em>vs</em> −4.9%) (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl1/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>).</p><p id="__p27">The reductions from baseline in LDL-C, TC, TG, and ApoB are consistent with the effect of rosuvastatin. The small reductions in HDL-C and ApoA-I are atypical.</p><p id="__p28">Summary statistics for the plasma and urine MVA parameters are presented in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl2/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a>.</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="tbl2"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl2/" target="table" rid-ob="ob-tbl2" rid-figpopup="tbl2" class="table img_link icnblk_img figpopup"><img alt="Table 2" title="Table 2" class="small-thumb" src="./PMC1874466_files/saved_resource(1)" src-large="/pmc/articles/PMC1874466/table/tbl2/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl2/" target="table" rid-figpopup="tbl2" rid-ob="ob-tbl2">Table 2</a></div><!--caption a4--><div><span>Summary of plasma and urine mevalonic acid parameters after morning and evening administration of rosuvastatin.</span></div></div></div><p id="__p29">During the course of the 14 day treatment period, the mean percent reduction in peak plasma MVA concentration was −25.9% with morning dosing and −31.0% with evening dosing (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl2/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a>). The mean percent reductions in plasma AUC(0,24 h) values for MVA were −29.9% and −32.6% after morning and evening dosing, respectively. The plasma MVA concentration-time curves are presented in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/figure/fig01/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="fig01" rid-ob="ob-fig01" co-legend-rid="lgnd_fig01"><span>Figure 1</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="fig01" co-legend-rid="lgnd_fig01"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/figure/fig01/" target="figure" rid-figpopup="fig01" rid-ob="ob-fig01"><img src="./PMC1874466_files/bcp0054-0472-f1.gif" class="small-thumb" alt="Figure 1" title="Figure 1" src-large="/pmc/articles/PMC1874466/bin/bcp0054-0472-f1.jpg"></a><div class="icnblk_cntnt" id="lgnd_fig01"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/figure/fig01/" target="figure" rid-figpopup="fig01" rid-ob="ob-fig01">Figure 1</a></div><!--caption a4--><div><span>Geometric mean plasma mevalonic acid concentration-time profiles before, after morning and evening administration of rosuvastatin. ▴ morning pre-dose, ▪ evening pre-dose, ▵ morning post-dose, □ evening post-dose.</span></div></div></div><p id="__p30">Over the same period, the mean percent reductions in 24 h urinary excretion of MVA were −33.6% and −29.2% after morning and evening dosing, respectively (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl2/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a>).</p><p id="__p31" class="p p-last">The 90% CIs for the difference in mean percent change from baseline at day 14 between the morning and evening treatment groups for plasma MVA AUC(0,24 h) and urinary excretion of MVA were −3.47, 8.10 and −12.76, 3.81, respectively (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl2/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a>).</p></div><div id="__sec14" class="sec"><h3>Pharmacokinetics</h3><p id="__p32" class="p p-first">From inspection of trough plasma rosuvastatin concentration-time profiles, it was apparent that steady state was attained within 8 days of initiating once-daily rosuvastatin administration (with both morning and evening dosing regimens). Under steady-state conditions, the mean trough plasma rosuvastatin concentration was approximately 0.6 ng ml<sup>−1</sup> in both treatment groups. Mean plasma concentration-time profiles on day 14 follow-ing morning or evening dosing were virtually super-imposable (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/figure/fig02/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span>Figure 2</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="fig02" co-legend-rid="lgnd_fig02"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/figure/fig02/" target="figure" rid-figpopup="fig02" rid-ob="ob-fig02"><img src="./PMC1874466_files/bcp0054-0472-f2.gif" class="small-thumb" alt="Figure 2" title="Figure 2" src-large="/pmc/articles/PMC1874466/bin/bcp0054-0472-f2.jpg"></a><div class="icnblk_cntnt" id="lgnd_fig02"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/figure/fig02/" target="figure" rid-figpopup="fig02" rid-ob="ob-fig02">Figure 2</a></div><!--caption a4--><div><span>Geometric mean plasma rosuvastatin concentration-time profiles on day 14 after morning (♦) and evening (▪) administration of rosuvastatin.</span></div></div></div><p id="__p33">The apparent rate of absorption of rosuvastatin was essentially the same following morning and evening dosing (median <em>t</em><sub>max</sub> 3.0 h) (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl3/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl3" rid-ob="ob-tbl3" co-legend-rid=""><span>Table 3</span></a>). Likewise, the degree of systemic exposure was very similar: mean <em>C</em><sub>max</sub> values of 4.58 and 4.54 ng ml<sup>−1</sup>, and mean AUC(0,24 h) values of 40.1 and 42.7 ng ml<sup>−1</sup> h following morning and evening dosing, respectively. In addition, mean plasma <em>t</em><sub>1/2</sub> values were similar (31.3 and 26.5 h), supporting no diurnal variation in the disposition of rosuvastatin.</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="tbl3"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl3/" target="table" rid-ob="ob-tbl3" rid-figpopup="tbl3" class="table img_link icnblk_img figpopup"><img alt="Table 3" title="Table 3" class="small-thumb" src="./PMC1874466_files/saved_resource(2)" src-large="/pmc/articles/PMC1874466/table/tbl3/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl3/" target="table" rid-figpopup="tbl3" rid-ob="ob-tbl3">Table 3</a></div><!--caption a4--><div><span>Summary of pharmacokinetic parameters for rosuvastatin after morning and evening administration of rosuvastatin.</span></div></div></div><p id="__p34" class="p p-last">Any difference greater than 2% in the pharmacokinetic parameters (<em>C</em><sub>max</sub> and AUC(0,24 h)) for rosuvastatin between the morning and evening dosing regimens was excluded by the 90% CIs (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/table/tbl3/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl3" rid-ob="ob-tbl3" co-legend-rid=""><span>Table 3</span></a>).</p></div><div id="__sec15" class="sec sec-last"><h3>Safety and tolerability</h3><p id="__p35" class="p p-first">Rosuvastatin proved to be well tolerated over the two 14 day treatment periods, with no significant changes in laboratory parameters and no serious adverse events.</p><p id="__p36" class="p p-last">One volunteer (male, 43 years) was withdrawn from the trial because of transient nonspecific ECG changes (T-wave flattening, primarily in the lateral leads), which occurred 3.5 h after the first dose of rosuvastatin. The volunteer was asymptomatic and the T-wave abnormality resolved within 15 h of dosing. Food intake can lead to similar ECG changes in healthy subjects up to 5 h after ingestion [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b25" rid="b25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035821" role="button" aria-expanded="false" aria-haspopup="true">25</a>]. Food may have been the causative factor for the changes noted in this volunteer, as he received food 1.5 h prior to the appearance of the abnormality.</p></div></div><div id="__sec16" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-17"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-18">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec16title">Discussion</h2><p id="__p37" class="p p-first">This trial was conducted to compare the pharmacodynamics and multiple-dose pharmacokinetics of rosuvastatin following morning and evening administration in healthy volunteers. The results show that rosuvastatin was equally effective in lowering serum LDL-C concentrations after morning or evening administration. In keeping with this finding, the steady-state pharmacokinetics of rosuvastatin were very similar after morning and evening administration. This characteristic of dose-time independence for both pharmacodynamics and pharmacokinetics differentiates rosuvastatin from other marketed statins.</p><p id="__p38">Fluvastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b10" rid="b10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035838" role="button" aria-expanded="false" aria-haspopup="true">10</a>], lovastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b11" rid="b11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035833" role="button" aria-expanded="false" aria-haspopup="true">11</a>], pravastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b12" rid="b12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035844" role="button" aria-expanded="false" aria-haspopup="true">12</a>], and simvastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b13" rid="b13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035825" role="button" aria-expanded="false" aria-haspopup="true">13</a>] all exert less pronounced LDL-C-regulating effects following morning compared with evening administration. Atorvastatin appears to be the only statin to share with rosuvastatin the characteristic of dose-time independence for pharmacodynamics [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b26" rid="b26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035829" role="button" aria-expanded="false" aria-haspopup="true">26</a>]. The fact that both atorvastatin and rosuvastatin have relatively long plasma half-lives may be of relevance to this common characteristic. However, atorvastatin, unlike rosuvastatin, shows diurnal differences in plasma exposure: lower systemic bioavailability (plasma AUC values reduced by 30%) was observed after evening compared with morning administration [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b26" rid="b26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035823" role="button" aria-expanded="false" aria-haspopup="true">26</a>].</p><p id="__p39">The reductions in serum LDL-C concentrations observed in this trial (−41 to −44%) closely match those obtained in hypercholesterolaemic patients following treatment with rosuvastatin 10 mg once daily for 6 weeks (approximately −48%) [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b14" rid="b14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035840" role="button" aria-expanded="false" aria-haspopup="true">14</a>]. While the reductions in TC, TG and ApoB concentrations observed in this trial are consistent with the effect of rosuvastatin on LDL-C, the small reductions in HDL-C and ApoA-I concentrations are less readily explainable. Data from dose-ranging [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b14" rid="b14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035828" role="button" aria-expanded="false" aria-haspopup="true">14</a>] and Phase-III [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b15" rid="b15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_130035819" role="button" aria-expanded="false" aria-haspopup="true">15</a>–<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b18" rid="b18" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">18</a>] trials show that rosuvastatin (1–80 mg) consistently raises HDL-C in dyslipidaemic patients. It is likely that the atypical decrease in HDL-C seen in this trial is the result of the relatively short treatment period (2 weeks) and the fact that volun-teers were required to have baseline LDL-C concentrations &lt; 4.14 mmol l<sup>−1</sup> and baseline TG concentrations ≤ 3.39 mmol l<sup>−1</sup>.</p><p id="__p40">The marked reductions in plasma and urine MVA after morning and evening dosing are consistent with the observed reductions in LDL-C and with the inhibition of HMG-CoA reductase. In addition, the similar reductions in MVA between morning and evening dosing concur with the similar pharmacodynamics and pharmacokinetics between morning and evening dosing.</p><p id="__p41" class="p p-last">In conclusion, the results of this trial indicate that the therapeutic benefit of rosuvastatin is not dose-time de-pendent, and that morning or evening administration is equally effective in regulating lipid levels. In addition, the pharmacokinetics of rosuvastatin were independent of time of dosing.</p></div><div id="__ackid839840" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-19"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-20">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ackid839840title">Acknowledgments</h2><div class="sec"><p id="__p42">The authors thank Elizabeth Eaton PhD for manuscript preparation.</p></div></div><div id="__fn-groupid288082" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-21"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-22">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__fn-groupid288082title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn1"><sup>†</sup>Trials 4522IL/0048, 0012 and 0053, 0057, and 0058.</p></div></div><div id="__ref-listid839846" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-23"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-24">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ref-listid839846title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="b1">1. <span class="citation">Bucher HC, Griffith LE, Guyatt GH. Systematic review on the risk and benefit of different cholesterol-lowering interventions. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>1999;<span class="ref-vol">19</span>:187–195.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9974397" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b2">2. <span class="citation">Knopp RH. Drug treatment of lipid disorders. <span><span class="ref-journal">N Engl J Med. </span>1999;<span class="ref-vol">341</span>:498–511.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10441607" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b3">3. <span class="citation">Rubenfire M, Coletti AT, Mosca L. Treatment strategies for management of serum lipids: lessons learned from lipid metabolism, recent clinical trials, and experience with the HMG CoA reductase inhibitors. <span><span class="ref-journal">Prog Cardiovasc Dis. </span>1998;<span class="ref-vol">41</span>:95–116.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9790412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b4">4. <span class="citation">Goldstein JL, Brown MS. Regulation of the mevalonate pathway. <span><span class="ref-journal">Nature. </span>1990;<span class="ref-vol">343</span>:425–430.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/1967820" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b5">5. <span class="citation">Aguilar-Salinas CA, Barrett H, Schonfeld G. Metabolic modes of action of the statins in the hyperlipoproteinemias. <span><span class="ref-journal">Atherosclerosis. </span>1998;<span class="ref-vol">141</span>:203–207.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9862169" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b6">6. <span class="citation">Davignon J, Montigny M, Dufour R. HMG-CoA reductase inhibitors: a look back and a look ahead. <span><span class="ref-journal">Can J Cardiol. </span>1992;<span class="ref-vol">8</span>:843–864.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/1423005" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b7">7. <span class="citation">Lennernäs H, Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. <span><span class="ref-journal">Clin Pharmacokinet. </span>1997;<span class="ref-vol">32</span>:403–425.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9160173" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b8">8. <span class="citation">Parker TS, McNamara DJ, Brown C, et al.  Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>1982;<span class="ref-vol">79</span>:3037–3041.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC346344/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/6953446" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b9">9. <span class="citation">Jones PJ, Schoeller DA. Evidence for diurnal periodicity in human cholesterol synthesis. <span><span class="ref-journal">J Lipid Res. </span>1990;<span class="ref-vol">31</span>:667–673.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/2351871" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b10">10. <span class="citation">Levy RI, Troendle AJ, Fattu JM. A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin. <span><span class="ref-journal">Circulation. </span>1993;<span class="ref-vol">87</span>(Suppl):III45–53.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8462180" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b11">11. <span class="citation">Illingworth DR. Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia. <span><span class="ref-journal">Clin Pharmacol Ther. </span>1986;<span class="ref-vol">40</span>:338–343.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/3638181" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b12">12. <span class="citation">Hunninghake DB, Mellies MJ, Goldberg AC, et al.  Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing. <span><span class="ref-journal">Atherosclerosis. </span>1990;<span class="ref-vol">85</span>:219–227.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/2129319" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b13">13. <span class="citation">Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y. Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study. <span><span class="ref-journal">Arterioscler Thromb. </span>1991;<span class="ref-vol">11</span>:816–826.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/2065035" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b14">14. <span class="citation">Olsson AG, Pears J, McKellar J, Mizan J, Raza A. Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. <span><span class="ref-journal">Am J Cardiol. </span>2001;<span class="ref-vol">88</span>:504–508.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11524058" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b15">15. <span class="citation">Davidson M, Ma P, Stein EA, et al.  Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. <span><span class="ref-journal">Am J Cardiol. </span>2002;<span class="ref-vol">89</span>:268–275.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11809427" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b16">16. <span class="citation">Paoletti R, Fahmy M, Mahla G, Caplan R, Raza A. Rosuvastatin is more effective than pravastatin or simvastatin at improving the lipid profiles of hypercholesterolaemic patients. <span><span class="ref-journal">Atherosclerosis. </span>2001;<span class="ref-vol">2</span>(Suppl 2):87–164.</span></span></div><div class="ref-cit-blk half_rhythm" id="b17">17. <span class="citation">Stein EA, Strutt KL, Miller E, Southworth H. Rosuvastatin (20, 40 and 80 mg) reduces LDL-C, raises HDL-C and achieves treatment goals more effectively than atorvastatin (20, 40 and 80 mg) in patients with heterozygous familial hypercholesterolaemia. <span><span class="ref-journal">Atherosclerosis. </span>2001;<span class="ref-vol">2</span>(Suppl 2):90–176.</span></span></div><div class="ref-cit-blk half_rhythm" id="b18">18. <span class="citation">Hunninghake DB, Chitra RR, Simonson SG, Schneck DW. Treatment of hypertriglyceridemic patients with rosuvastatin. <span><span class="ref-journal">Diabetes. </span>2001;<span class="ref-vol">50</span>(Suppl 2):143–574.</span></span></div><div class="ref-cit-blk half_rhythm" id="b19">19. <span class="citation">Warwick MJ, Dane AL, Raza A, Schneck DW. Single- and multiple-dose pharmacokinetics and safety of the new HMG-CoA reductase inhibitor ZD4522. <span><span class="ref-journal">Atherosclerosis. </span>2000;<span class="ref-vol">151</span>:39.</span> ((Abstract) MoP19: W6)</span></div><div class="ref-cit-blk half_rhythm" id="b20">20. <span class="citation">Martin PD, Dane AL, Nwose OM, Schneck DW, Warwick MJ. No effect of age or gender on the pharmacokinetics of rosuvastatin – a new HMG-CoA reductase inhibitor. <span><span class="ref-journal">J Clin Pharmacol. </span>2002</span> in press.  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12362926" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b21">21. <span class="citation">Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifugation. <span><span class="ref-journal">Clin Chem. </span>1972;<span class="ref-vol">18</span>:499–502.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/4337382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b22">22. <span class="citation">Abrar M, Martin PD. Validation and application of an assay for the determination of mevalonic acid in human plasma by liquid chromatography tandem mass spectrometry. <span><span class="ref-journal">J Chromatogr B. </span>2002;<span class="ref-vol">773</span>:103–111.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12031835" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b23">23. <span class="citation">Woollen BH, Holme PC, Northway WJ, Martin PD. Determination of mevalonic acid in human urine as mevalonic acid lactone by gas chromatography-mass spectrometry. <span><span class="ref-journal">J Chromatogr B. </span>2001;<span class="ref-vol">760</span>:179–184.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11522061" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b24">24. <span class="citation">Hull CK, Penman AD, Smith CK, Martin PD. Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass-spectrometric detection. <span><span class="ref-journal">J Chromatogr B. </span>2002;<span class="ref-vol">772</span>:219–228.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12007766" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b25">25. <span class="citation">Widerlöv E, Jostell KG, Claesson L, et al.  Influence of food intake on electrocardiograms of healthy male volunteers. <span><span class="ref-journal">Eur J Clin Pharmacol. </span>1999;<span class="ref-vol">55</span>:619–624.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10638388" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b26">26. <span class="citation">Cilla DD, Gibson DM, Whitfield LR, Sedman AJ. Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. <span><span class="ref-journal">J Clin Pharmacol. </span>1996;<span class="ref-vol">36</span>:604–609.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8844442" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#__abstractid898026title">Abstract</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#__sec5title">Introduction</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#__sec6title">Methods</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#__sec8title">Pharmacodynamic evaluations</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#__sec12title">Results</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#__sec16title">Discussion</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#__ackid839840title">Acknowledgments</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#__fn-groupid288082title">Footnotes</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#__ref-listid839846title">References</a></li></ul></div></div><!--post-content--><hr class="whole_rhythm no_bottom_margin"><div class="courtesy-note no_margin small">Articles from <span class="acknowledgment-journal-title">British Journal of Clinical Pharmacology</span> are provided here courtesy of <strong>British Pharmacological Society</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="try-button"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/?report=reader"><img src="./PMC1874466_files/3838809" alt="PubReader format: click here to try"></a></div><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/epub/">ePub (beta)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/pdf/bcp0054-0472.pdf">PDF (95K)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" data-citationid="PMC1874466" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1874466%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC1874466_files/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1874466%2F&amp;text=Pharmacodynamic%20effects%20and%20pharmacokinetics%20of%20a%20new%20HMG-CoA%20reductase%20inhibitor%2C%20rosuvastatin%2C%20after%20morning%20or%20evening%20administration%20in%20healthy%20volunteers" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC1874466_files/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1874466%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC1874466_files/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="12445025" data-aiid="1874466" data-aid="1874466" data-iid="144393" data-domainid="279" data-domain="brjclinpharm" data-accid="PMC1874466" data-md5="3acb1d53c5f8e48421ef2e50bc7f65f6">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-27" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-27" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input type="hidden" name="absid" id="absid" value="1874466"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="http://www.ncbi.nlm.nih.gov/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:&#39;#favUL&#39;,starExists:true,createCollectionUrl:&#39;#&#39;,manageCollectionsUrl:&#39;/myncbi/collections/&#39;"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="http://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input type="submit" class="button_apply" name="addtocollection" value="1"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-29" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-29" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/18042475" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study.</a><span class="source">[Clin Ther. 2007]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-31" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Li Y, Jiang X, Lan K, Zhang R, Li X, Jiang Q. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Ther. 2007 Oct; 29(10):2194-203. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/14512129" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers.</a><span class="source">[Clin Ther. 2003]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-33" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Martin PD, Warwick MJ, Dane AL, Cantarini MV. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Ther. 2003 Aug; 25(8):2215-24. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/20399994" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: a randomized, open-label, ascending single- and multiple-dose study.</a><span class="source">[Clin Ther. 2010]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-35" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Li XN, Xu HR, Chen WL, Chu NN, Zhu JR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Ther. 2010 Mar; 32(3):575-87. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/12481202" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="true" aria-haspopup="true">Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor.</a><span class="source">[Cardiovasc Drug Rev. 2002]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-37" aria-live="assertive" aria-hidden="false" style="top: 566.953px; left: 511.453px; display: block;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Olsson AG, McTaggart F, Raza A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cardiovasc Drug Rev. 2002 Winter; 20(4):303-28. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/12211221" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin.</a><span class="source">[J Clin Pharmacol. 2002]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-39" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">White CM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Clin Pharmacol. 2002 Sep; 42(9):963-70. </em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=12445025&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=12445025&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-41" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-41" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727765/" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Development of a Stability-Indicating Stereoselective Method for Quantification of the Enantiomer in the Drug Substance and Pharmaceutical Dosage Form of Rosuvastatin Calcium by an Enhanced Approach</a><span class="source">[Scientia Pharmaceutica. 2014]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-43" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Rajendra Reddy G, Ravindra Reddy P, Siva Jyothi P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Scientia Pharmaceutica. 2014 Dec 5; 83(2)279-296</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642150/" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Simultaneous determination of rosuvastatin and amlodipine in human plasma using tandem mass spectrometry: Application to disposition kinetics</a><span class="source">[Journal of Advanced Research. ...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-45" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Narapusetti A, Bethanabhatla SS, Sockalingam A, Repaka N, Saritha V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Journal of Advanced Research. 2014 Sep 6; 6(6)931-940</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354399/" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects</a><span class="source">[Drug Design, Development and T...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-47" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jung JA, Lee SY, Kim JR, Ko JW, Jang SB, Nam SY, Huh W. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drug Design, Development and Therapy. 2015 Mar 2; 9745-752</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120018/" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1-Related Variability in Pharmacodynamics of Rosuvastatin</a><span class="source"></span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-49" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Rose RH, Neuhoff S, Abduljalil K, Chetty M, Rostami-Hodjegan A, Jamei M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">CPT: Pharmacometrics &amp; Systems Pharmacology. 2014 Jul 9; 3(7)e124-</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063287/" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants</a><span class="source">[Pharmacogenetics and genomics....]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-51" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ho RH, Choi L, Lee W, Mayo G, Schwarz UI, Tirona RG, Bailey DG, Stein CM, Kim RB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pharmacogenetics and genomics. 2007 Aug; 17(8)647-656</em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/citedby/" ref="reftype=relart&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-53" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-53" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=1874466" ref="reftype=Compound&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-55" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=1874466" ref="reftype=MedGen&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-57" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/12445025/" ref="reftype=PubMed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-59" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=1874466" ref="reftype=Substance&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-61" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-63" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-63" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState(&#39;ClearHT&#39;)">Clear</a><a href="javascript:historyDisplayState(&#39;HTOff&#39;)" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState(&#39;HTOn&#39;)" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c269704fcfad5917683b7">Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibito...</a><div class="ralinkpop offscreen_noflow">Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers<div class="brieflinkpopdesc">British Journal of Clinical Pharmacology. 2002 Nov; 54(5)472</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=2" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c26947fd84438f0e9ce66">PMC1874466 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c267c04fcfad591767e80">The Risk of Overanticoagulation with Antibiotic Use in Outpatients on Stable War...</a><div class="ralinkpop offscreen_noflow">The Risk of Overanticoagulation with Antibiotic Use in Outpatients on Stable Warfarin Regimens<div class="brieflinkpopdesc">Journal of General Internal Medicine. 2005 Jul; 20(7)653</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=4" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c26787fd84438f0e9c8b4">PMC1490169 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c265404fcfad5917677c1">Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schi...</a><div class="ralinkpop offscreen_noflow">Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics<div class="brieflinkpopdesc">BMC Psychiatry. 2005; 5()26</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState(&#39;HTOn&#39;)">Turn recording back on</a></p>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p6" name="crb--__p6" rid="__p6" style="position: absolute; visibility: visible; width: 370px; top: 1166px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-65"><ul>
<li class="two_line" reference_id="b1">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9974397/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Systematic review on the risk and benefit of different cholesterol-lowering interventions.</a><span class="one_line_source">[Arterioscler Thromb Vasc Biol.  1999]</span><div class="alt-note">
<div class="authors">Bucher HC, Griffith LE, Guyatt GH</div>
<div class="citation">Arterioscler Thromb Vasc Biol. 1999 Feb; 19(2):187-95.</div>
</div>
</li>
<li class="two_line" reference_id="b3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9790412/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Treatment strategies for management of serum lipids: lessons learned from lipid metabolism, recent clinical trials, and experience with the HMG CoA reductase inhibitors.</a><span class="one_line_source">[Prog Cardiovasc Dis.  1998]</span><div class="alt-note">
<div class="authors">Rubenfire M, Coletti AT, Mosca L</div>
<div class="citation">Prog Cardiovasc Dis. 1998 Sep-Oct; 41(2):95-116.</div>
</div>
</li>
<li class="two_line" reference_id="b4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/1967820/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Regulation of the mevalonate pathway.</a><span class="one_line_source">[Nature.  1990]</span><div class="alt-note">
<div class="authors">Goldstein JL, Brown MS</div>
<div class="citation">Nature. 1990 Feb 1; 343(6257):425-30.</div>
</div>
</li>
<li class="two_line" reference_id="b5" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9862169/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Metabolic modes of action of the statins in the hyperlipoproteinemias.</a><span class="one_line_source">[Atherosclerosis.  1998]</span><div class="alt-note">
<div class="authors">Aguilar-Salinas CA, Barrett H, Schonfeld G</div>
<div class="citation">Atherosclerosis. 1998 Dec; 141(2):203-7.</div>
</div>
</li>
<li class="two_line" reference_id="b7" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9160173/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.</a><span class="one_line_source">[Clin Pharmacokinet.  1997]</span><div class="alt-note">
<div class="authors">Lennernäs H, Fager G</div>
<div class="citation">Clin Pharmacokinet. 1997 May; 32(5):403-25.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p7" name="crb--__p7" rid="__p7" style="position: absolute; visibility: visible; width: 370px; top: 1324px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-66"><ul>
<li class="two_line" reference_id="b8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/6953446/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  1982]</span><div class="alt-note">
<div class="authors">Parker TS, McNamara DJ, Brown C, Garrigan O, Kolb R, Batwin H, Ahrens EH Jr</div>
<div class="citation">Proc Natl Acad Sci U S A. 1982 May; 79(9):3037-41.</div>
</div>
</li>
<li class="two_line" reference_id="b9">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/2351871/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Evidence for diurnal periodicity in human cholesterol synthesis.</a><span class="one_line_source">[J Lipid Res.  1990]</span><div class="alt-note">
<div class="authors">Jones PJ, Schoeller DA</div>
<div class="citation">J Lipid Res. 1990 Apr; 31(4):667-73.</div>
</div>
</li>
<li class="two_line" reference_id="b2" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/10441607/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Drug treatment of lipid disorders.</a><span class="one_line_source">[N Engl J Med.  1999]</span><div class="alt-note">
<div class="authors">Knopp RH</div>
<div class="citation">N Engl J Med. 1999 Aug 12; 341(7):498-511.</div>
</div>
</li>
<li class="two_line" reference_id="b10" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8462180/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin.</a><span class="one_line_source">[Circulation.  1993]</span><div class="alt-note">
<div class="authors">Levy RI, Troendle AJ, Fattu JM</div>
<div class="citation">Circulation. 1993 Apr; 87(4 Suppl):III45-53.</div>
</div>
</li>
<li class="two_line" reference_id="b11" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/3638181/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia.</a><span class="one_line_source">[Clin Pharmacol Ther.  1986]</span><div class="alt-note">
<div class="authors">Illingworth DR</div>
<div class="citation">Clin Pharmacol Ther. 1986 Sep; 40(3):338-43.</div>
</div>
</li>
<li class="two_line" reference_id="b12" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/2129319/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing.</a><span class="one_line_source">[Atherosclerosis.  1990]</span><div class="alt-note">
<div class="authors">Hunninghake DB, Mellies MJ, Goldberg AC, Kuo PT, Kostis JB, Schrott HG, Insull W Jr, Pan HY</div>
<div class="citation">Atherosclerosis. 1990 Dec; 85(2-3):219-27.</div>
</div>
</li>
<li class="two_line" reference_id="b13" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/2065035/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study.</a><span class="one_line_source">[Arterioscler Thromb.  1991]</span><div class="alt-note">
<div class="authors">Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y</div>
<div class="citation">Arterioscler Thromb. 1991 Jul-Aug; 11(4):816-26.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p8" name="crb--__p8" rid="__p8" style="position: absolute; visibility: visible; width: 370px; top: 1440px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-67"><ul><li class="two_line" reference_id="b14">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/11524058/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia.</a><span class="one_line_source">[Am J Cardiol.  2001]</span><div class="alt-note">
<div class="authors">Olsson AG, Pears J, McKellar J, Mizan J, Raza A</div>
<div class="citation">Am J Cardiol. 2001 Sep 1; 88(5):504-8.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p9" name="crb--__p9" rid="__p9" style="position: absolute; visibility: visible; width: 370px; top: 1535px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-68"><ul><li class="two_line" reference_id="b20">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12362926/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitor.</a><span class="one_line_source">[J Clin Pharmacol.  2002]</span><div class="alt-note">
<div class="authors">Martin PD, Dane AL, Nwose OM, Schneck DW, Warwick MJ</div>
<div class="citation">J Clin Pharmacol. 2002 Oct; 42(10):1116-21.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p16" name="crb--__p16" rid="__p16" style="position: absolute; visibility: visible; width: 370px; top: 2362px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-69"><ul><li class="two_line" reference_id="b21">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/4337382/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.</a><span class="one_line_source">[Clin Chem.  1972]</span><div class="alt-note">
<div class="authors">Friedewald WT, Levy RI, Fredrickson DS</div>
<div class="citation">Clin Chem. 1972 Jun; 18(6):499-502.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p17" name="crb--__p17" rid="__p17" style="position: absolute; visibility: visible; width: 370px; top: 2583px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-70"><ul>
<li class="two_line" reference_id="b22">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12031835/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Validation and application of an assay for the determination of mevalonic acid in human plasma by liquid chromatography tandem mass spectrometry.</a><span class="one_line_source">[J Chromatogr B Analyt Technol Biomed Life Sci.  2002]</span><div class="alt-note">
<div class="authors">Abrar M, Martin PD</div>
<div class="citation">J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 25; 773(2):103-11.</div>
</div>
</li>
<li class="two_line" reference_id="b23">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/11522061/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Determination of mevalonic acid in human urine as mevalonic acid lactone by gas chromatography-mass spectrometry.</a><span class="one_line_source">[J Chromatogr B Biomed Sci Appl.  2001]</span><div class="alt-note">
<div class="authors">Woollen BH, Holme PC, Northway WJ, Martin PD</div>
<div class="citation">J Chromatogr B Biomed Sci Appl. 2001 Aug 25; 760(1):179-84.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p18" name="crb--__p18" rid="__p18" style="position: absolute; visibility: visible; width: 370px; top: 2906px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-71"><ul><li class="two_line" reference_id="b24">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12007766/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection.</a><span class="one_line_source">[J Chromatogr B Analyt Technol Biomed Life Sci.  2002]</span><div class="alt-note">
<div class="authors">Hull CK, Penman AD, Smith CK, Martin PD</div>
<div class="citation">J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 5; 772(2):219-28.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p36" name="crb--__p36" rid="__p36" style="position: absolute; visibility: visible; width: 370px; top: 5427px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-72"><ul><li class="two_line" reference_id="b25">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/10638388/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Influence of food intake on electrocardiograms of healthy male volunteers.</a><span class="one_line_source">[Eur J Clin Pharmacol.  1999]</span><div class="alt-note">
<div class="authors">Widerlöv E, Jostell KG, Claesson L, Odlind B, Keisu M, Freyschuss U</div>
<div class="citation">Eur J Clin Pharmacol. 1999 Nov; 55(9):619-24.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p38" name="crb--__p38" rid="__p38" style="position: absolute; visibility: visible; width: 370px; top: 5739px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-73"><ul>
<li class="two_line" reference_id="b10">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8462180/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin.</a><span class="one_line_source">[Circulation.  1993]</span><div class="alt-note">
<div class="authors">Levy RI, Troendle AJ, Fattu JM</div>
<div class="citation">Circulation. 1993 Apr; 87(4 Suppl):III45-53.</div>
</div>
</li>
<li class="two_line" reference_id="b11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/3638181/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia.</a><span class="one_line_source">[Clin Pharmacol Ther.  1986]</span><div class="alt-note">
<div class="authors">Illingworth DR</div>
<div class="citation">Clin Pharmacol Ther. 1986 Sep; 40(3):338-43.</div>
</div>
</li>
<li class="two_line" reference_id="b12">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/2129319/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing.</a><span class="one_line_source">[Atherosclerosis.  1990]</span><div class="alt-note">
<div class="authors">Hunninghake DB, Mellies MJ, Goldberg AC, Kuo PT, Kostis JB, Schrott HG, Insull W Jr, Pan HY</div>
<div class="citation">Atherosclerosis. 1990 Dec; 85(2-3):219-27.</div>
</div>
</li>
<li class="two_line" reference_id="b13" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/2065035/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study.</a><span class="one_line_source">[Arterioscler Thromb.  1991]</span><div class="alt-note">
<div class="authors">Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y</div>
<div class="citation">Arterioscler Thromb. 1991 Jul-Aug; 11(4):816-26.</div>
</div>
</li>
<li class="two_line" reference_id="b26" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8844442/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening.</a><span class="one_line_source">[J Clin Pharmacol.  1996]</span><div class="alt-note">
<div class="authors">Cilla DD Jr, Gibson DM, Whitfield LR, Sedman AJ</div>
<div class="citation">J Clin Pharmacol. 1996 Jul; 36(7):604-9.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p39" name="crb--__p39" rid="__p39" style="position: absolute; visibility: visible; width: 370px; top: 5897px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-74"><ul>
<li class="two_line" reference_id="b14">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/11524058/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia.</a><span class="one_line_source">[Am J Cardiol.  2001]</span><div class="alt-note">
<div class="authors">Olsson AG, Pears J, McKellar J, Mizan J, Raza A</div>
<div class="citation">Am J Cardiol. 2001 Sep 1; 88(5):504-8.</div>
</div>
</li>
<li class="two_line" reference_id="b15">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/11809427/" ref="reftype=pubmed&amp;article-id=1874466&amp;issue-id=144393&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.</a><span class="one_line_source">[Am J Cardiol.  2002]</span><div class="alt-note">
<div class="authors">Davidson M, Ma P, Stein EA, Gotto AM Jr, Raza A, Chitra R, Hutchinson H</div>
<div class="citation">Am J Cardiol. 2002 Feb 1; 89(3):268-75.</div>
</div>
</li>
</ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="./PMC1874466_files/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-b1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Systematic review on the risk and benefit of different cholesterol-lowering interventions.<div class="authors">Bucher HC, Griffith LE, Guyatt GH</div><div class="citation">Arterioscler Thromb Vasc Biol. 1999 Feb; 19(2):187-95.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9974397/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b1">Ref list</a>]</p></div><div id="body-link-popper-b3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Treatment strategies for management of serum lipids: lessons learned from lipid metabolism, recent clinical trials, and experience with the HMG CoA reductase inhibitors.<div class="authors">Rubenfire M, Coletti AT, Mosca L</div><div class="citation">Prog Cardiovasc Dis. 1998 Sep-Oct; 41(2):95-116.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9790412/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b3">Ref list</a>]</p></div><div id="body-link-popper-b4" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Regulation of the mevalonate pathway.<div class="authors">Goldstein JL, Brown MS</div><div class="citation">Nature. 1990 Feb 1; 343(6257):425-30.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/1967820/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b4">Ref list</a>]</p></div><div id="body-link-popper-b5" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Metabolic modes of action of the statins in the hyperlipoproteinemias.<div class="authors">Aguilar-Salinas CA, Barrett H, Schonfeld G</div><div class="citation">Atherosclerosis. 1998 Dec; 141(2):203-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9862169/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b5">Ref list</a>]</p></div><div id="body-link-popper-b7" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.<div class="authors">Lennernäs H, Fager G</div><div class="citation">Clin Pharmacokinet. 1997 May; 32(5):403-25.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9160173/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b7">Ref list</a>]</p></div><div id="body-link-popper-b8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man.<div class="authors">Parker TS, McNamara DJ, Brown C, Garrigan O, Kolb R, Batwin H, Ahrens EH Jr</div><div class="citation">Proc Natl Acad Sci U S A. 1982 May; 79(9):3037-41.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/6953446/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b8">Ref list</a>]</p></div><div id="body-link-popper-b9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Evidence for diurnal periodicity in human cholesterol synthesis.<div class="authors">Jones PJ, Schoeller DA</div><div class="citation">J Lipid Res. 1990 Apr; 31(4):667-73.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/2351871/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b9">Ref list</a>]</p></div><div id="body-link-popper-b2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Drug treatment of lipid disorders.<div class="authors">Knopp RH</div><div class="citation">N Engl J Med. 1999 Aug 12; 341(7):498-511.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10441607/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b2">Ref list</a>]</p></div><div id="body-link-popper-b10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin.<div class="authors">Levy RI, Troendle AJ, Fattu JM</div><div class="citation">Circulation. 1993 Apr; 87(4 Suppl):III45-53.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8462180/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b10">Ref list</a>]</p></div><div id="body-link-popper-b11" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia.<div class="authors">Illingworth DR</div><div class="citation">Clin Pharmacol Ther. 1986 Sep; 40(3):338-43.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/3638181/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b11">Ref list</a>]</p></div><div id="body-link-popper-b12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing.<div class="authors">Hunninghake DB, Mellies MJ, Goldberg AC, Kuo PT, Kostis JB, Schrott HG, Insull W Jr, Pan HY</div><div class="citation">Atherosclerosis. 1990 Dec; 85(2-3):219-27.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/2129319/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b12">Ref list</a>]</p></div><div id="body-link-popper-b13" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study.<div class="authors">Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y</div><div class="citation">Arterioscler Thromb. 1991 Jul-Aug; 11(4):816-26.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/2065035/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b13">Ref list</a>]</p></div><div id="body-link-popper-b14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia.<div class="authors">Olsson AG, Pears J, McKellar J, Mizan J, Raza A</div><div class="citation">Am J Cardiol. 2001 Sep 1; 88(5):504-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11524058/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b14">Ref list</a>]</p></div><div id="body-link-popper-b18" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">18. <span class="citation">Hunninghake DB, Chitra RR, Simonson SG, Schneck DW. Treatment of hypertriglyceridemic patients with rosuvastatin. <span><span class="ref-journal">Diabetes. </span>2001;<span class="ref-vol">50</span>(Suppl 2):143–574.</span></span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b18">Ref list</a>]</div><div id="body-link-popper-b19" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">19. <span class="citation">Warwick MJ, Dane AL, Raza A, Schneck DW. Single- and multiple-dose pharmacokinetics and safety of the new HMG-CoA reductase inhibitor ZD4522. <span><span class="ref-journal">Atherosclerosis. </span>2000;<span class="ref-vol">151</span>:39.</span> ((Abstract) MoP19: W6)</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b19">Ref list</a>]</div><div id="body-link-popper-b20" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitor.<div class="authors">Martin PD, Dane AL, Nwose OM, Schneck DW, Warwick MJ</div><div class="citation">J Clin Pharmacol. 2002 Oct; 42(10):1116-21.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12362926/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b20">Ref list</a>]</p></div><div id="body-link-popper-b21" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.<div class="authors">Friedewald WT, Levy RI, Fredrickson DS</div><div class="citation">Clin Chem. 1972 Jun; 18(6):499-502.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/4337382/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b21">Ref list</a>]</p></div><div id="body-link-popper-b22" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Validation and application of an assay for the determination of mevalonic acid in human plasma by liquid chromatography tandem mass spectrometry.<div class="authors">Abrar M, Martin PD</div><div class="citation">J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 25; 773(2):103-11.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12031835/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b22">Ref list</a>]</p></div><div id="body-link-popper-b23" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Determination of mevalonic acid in human urine as mevalonic acid lactone by gas chromatography-mass spectrometry.<div class="authors">Woollen BH, Holme PC, Northway WJ, Martin PD</div><div class="citation">J Chromatogr B Biomed Sci Appl. 2001 Aug 25; 760(1):179-84.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11522061/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b23">Ref list</a>]</p></div><div id="body-link-popper-b24" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection.<div class="authors">Hull CK, Penman AD, Smith CK, Martin PD</div><div class="citation">J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 5; 772(2):219-28.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12007766/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b24">Ref list</a>]</p></div><div id="body-link-popper-b25" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Influence of food intake on electrocardiograms of healthy male volunteers.<div class="authors">Widerlöv E, Jostell KG, Claesson L, Odlind B, Keisu M, Freyschuss U</div><div class="citation">Eur J Clin Pharmacol. 1999 Nov; 55(9):619-24.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10638388/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b25">Ref list</a>]</p></div><div id="body-link-popper-b26" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening.<div class="authors">Cilla DD Jr, Gibson DM, Whitfield LR, Sedman AJ</div><div class="citation">J Clin Pharmacol. 1996 Jul; 36(7):604-9.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8844442/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b26">Ref list</a>]</p></div><div id="body-link-popper-b15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.<div class="authors">Davidson M, Ma P, Stein EA, Gotto AM Jr, Raza A, Chitra R, Hutchinson H</div><div class="citation">Am J Cardiol. 2002 Feb 1; 89(3):268-75.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11809427/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#b15">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <div class="breadcrumbs">You are here: 
            <span id="breadcrumb_text"><a href="http://www.ncbi.nlm.nih.gov/guide/">NCBI</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central (PMC)</a></span></div>
    <a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target="_blank" href="http://www.ncbi.nlm.nih.gov/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.35&amp;Time=2016-06-23T14:12:39-04:00&amp;Host=ptpmc201">Write to the Help Desk</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="./PMC1874466_files/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="http://www.nlm.nih.gov/" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="http://www.nih.gov/" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="http://www.dhhs.gov/" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="http://www.usa.gov/" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            
            <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Copyright</a> | <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html#disclaimer">Disclaimer</a> |
            <a href="http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a> | 
            <a href="http://www.ncbi.nlm.nih.gov/guide/browsers/">Browsers</a> | <a href="http://www.nlm.nih.gov/accessibility.html">Accessibility</a> | <a href="http://www.ncbi.nlm.nih.gov/About/glance/contact_info.html">Contact</a>
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="http://www.ncbi.nlm.nih.gov/">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url"><a href="http://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
        </div>
    </div>
    <script type="text/javascript" src="./PMC1874466_files/InstrumentPageStarterJS.js"> </script>    
    <script type="text/javascript" src="./PMC1874466_files/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div><div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 63.5938px; left: 408.188px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: none;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874466/#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: none;">Turn off</a></div></div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=brjclinpharm&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC1874466/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC7E8376854741_0014SID /projects/PMC/PMCViewer@4.35 ptpmc201 v4.1.r480124 Mon, Sep 28 2015 02:46:19 -->

<script type="text/javascript" src="./PMC1874466_files/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1" style="display: none;"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div><ul class="print-log"><li></li></ul><div class="ui-ncbipopper-arrow-image ui-ncbipopper-arrow-right" style="display: block; top: 566.953px; left: 893.453px; opacity: 1;">&nbsp;</div></body></html>